Efficacy and safety of Exubera (inhaled insulin) compared with subcutaneous human insulin therapy in adult subjects with type 2 diabetes mellitus: a long-term, outpatient, open-label, parallel-group comparative trial.
Phase of Trial: Phase III
Latest Information Update: 26 Jan 2010
At a glance
- Drugs Insulin; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 21 Jul 2008 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
- 03 Jan 2008 The expected completion date for this trial is now 1 Mar 2010.